Fidelity Investments
FBIO icon

Fidelity Investments’s Fortress Biotech FBIO Stock Holding History

Fidelity Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614 Buy
+220
New +$748 ﹤0.01% 5145
2025
Q4 		– Sell
-63
Closed -$233 – 5467
2025
Q3 		$233 Buy
+63
New +$159 ﹤0.01% 5144
2025
Q2 		– Sell
-1,950
Closed -$3.04K – 5380
2025
Q1 		$3.04K Sell
1,950
-18,799
-91% -$33.1K ﹤0.01% 4817
2024
Q4 		$42K Sell
20,749
-5,718
-22% -$10.4K ﹤0.01% 3927
2024
Q3 		$38.2K Buy
26,467
+1,806
+7% +$3.44K ﹤0.01% 3893
2024
Q2 		$42.2K Buy
24,661
+440
+2% +$798 ﹤0.01% 3701
2024
Q1 		$48.4K Sell
24,221
-20
-0.1% -$40 ﹤0.01% 3602
2023
Q4 		$73K Buy
24,241
+18,653
+334% +$49.3K ﹤0.01% 3350
2023
Q3 		$24.3K Sell
5,588
-13
-0.2% -$89 ﹤0.01% 3707
2023
Q2 		$46.2K Buy
5,601
+15
+0.3% +$148 ﹤0.01% 3469
2023
Q1 		$68.7K Hold
5,586
– – ﹤0.01% 3321
2022
Q4 		$54.9K Hold
5,586
– – ﹤0.01% 3412
2022
Q3 		$72K Sell
5,586
-431
-7% -$6.45K ﹤0.01% 3358
2022
Q2 		$76K Buy
6,017
+414
+7% +$6.13K ﹤0.01% 3411
2022
Q1 		$114K Buy
+5,603
New +$153K ﹤0.01% 3405
2021
Q3 		– Hold
0
– – – 4555
2021
Q2 		– Hold
0
– – – 4437
2013
Q4 		– Sell
-335,045
Closed -$35.3M – 2640
2013
Q3 		$35.3M Buy
335,045
+96,734
+41% +$11.9M 0.01% 1444
2013
Q2 		$30.7M Buy
+238,311
New +$35.1M 0.01% 1472

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Fidelity Investments's FBIO Position: Q1 2026 in Review

Fidelity Investments opened a new position in Fortress Biotech (FBIO) in Q1 2026: 220 shares worth $614. The stake represents ﹤0.01% of the portfolio and ranks #5145 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in FBIO as recently as Q3 2025.

Fidelity Investments first reported a position in FBIO in Q2 2013 and has held it in 17 quarters since. The position peaked at $35.3M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Fidelity Investments held 220 shares of Fortress Biotech worth $614 as of Q1 2026.
  • Fortress Biotech was a new Fidelity Investments position in Q1 2026.
  • Fortress Biotech made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5145 holding.
  • Fidelity Investments first reported a position in Fortress Biotech in Q2 2013 and has held it in 17 quarters since.
  • Fidelity Investments's Fortress Biotech position peaked at $35.3M in Q3 2013.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.